National registry for children with Juvenile Idiopathic Arthritis in Canada
The Canadian Alliance of Pediatric Rheumatology Investigators National Juvenile Idiopathic Arthritis Registry
This study is collecting information about children in Canada with Juvenile Idiopathic Arthritis to see how the disease affects them and how different treatments work over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1238 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | University of British Columbia Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 15 sites (Calgary, Alberta and 14 other locations) |
| Trial ID | NCT03245801 on ClinicalTrials.gov |
What this trial studies
The CAPRI National Juvenile Idiopathic Arthritis Registry collects longitudinal data on Canadian children diagnosed with Juvenile Idiopathic Arthritis (JIA) to better understand the disease's course, outcomes, and adverse events. This observational registry aims to inform healthcare decisions and improve treatment strategies by leveraging data from pediatric rheumatology experts across Canada. By tracking newly diagnosed patients and those from previous studies, the registry seeks to provide insights into the effectiveness of various treatment approaches and the overall prognosis for affected children.
Who should consider this trial
Good fit: Ideal candidates for this registry are children newly diagnosed with JIA within the last three months.
Not a fit: Patients with an unconfirmed JIA diagnosis or those diagnosed more than three months prior may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better health outcomes for children with Juvenile Idiopathic Arthritis.
How similar studies have performed: Other registries and studies focused on JIA have shown success in improving understanding and treatment of the condition, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients newly diagnosed with JIA within the last 3 months 2. All patients who participated in the original ReACCh-Out study 3. LEAP study patients from 'newly diagnosed' and 'ReACCh-Out' cohorts who have completed their two year follow up in LEAP Exclusion Criteria: 1. Patients with an unconfirmed JIA diagnosis 2. Patients diagnosed with JIA more than 3 months prior to the clinic visit, who were not followed in LEAP and /or ReACCh-Out studies. 3. If the family as a whole is unable to answer questionnaires in English or French
Where this trial is running
Calgary, Alberta and 14 other locations
- University of Calgary / Alberta Children's Hospital — Calgary, Alberta, Canada (Recruiting)
- University of Alberta — Edmonton, Alberta, Canada (Recruiting)
- BC Children's Hospital — Vancouver, British Columbia, Canada (Recruiting)
- University of Manitoba/Children's hospital research institute — Winnipeg, Manitoba, Canada (Recruiting)
- Memorial University/Janeway Childrens Health and Rehabilitation Centre — St. John's, Newfoundland and Labrador, Canada, Canada (Recruiting)
- IIWK Health Centre — Halifax, Nova Scotia, Canada (Recruiting)
- McMaster University/McMaster Children's Hospital — Hamilton, Ontario, Canada (Recruiting)
- London Health Sciences Centre — London, Ontario, Canada (Recruiting)
- Children's Hospital of Eastern Ontario — Ottawa, Ontario, Canada (Recruiting)
- Hospital for Sick Children — Toronto, Ontario, Canada (Recruiting)
- McGill University Health Centre — Montreal, Quebec, Canada (Recruiting)
- Université de Montréal — Montreal, Quebec, Canada (Recruiting)
- University of Sherbrooke — Sherbrooke, Quebec, Canada (Recruiting)
- Royal University Hospital — Saskatoon, Saskatchewan, Canada (Recruiting)
- CHU Québec - Universite Laval — Québec, Canada (Recruiting)
Study contacts
- Principal investigator: Adam Huber, MD — IIWK Health Centre, Halifax, Nova Scotia, Canada
- Study coordinator: Jaime Guzman, MD, FRCPC
- Email: jguzman@cw.bc.ca
- Phone: 604-875-2437
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.